Is The FDA Finally OK With CBD? – Medical Marijuana Program Connection

The FDA has yet to signal its support for over-the-counter CBD products. In fact, the government agency has issued many warnings to CBD manufacturers that make health claims. FDA officials also constantly reiterate their stance against mixing CBD into edibles.

However, there’s a bit of hope that the FDA is interested in revising its CBD policies. According to recent reports, the FDA held a virtual conference with leaders in the supplement industry to discuss the safety of using cannabinoids in OTC products. While the FDA didn’t mention CBD by name, most in the hemp industry believe the FDA will focus on this cannabinoid.

On the official Federal Register website, it shows the FDA held a recent virtual conference on June 14th with members of its Science Board. The “agenda” for this meeting was light on details, but it mentioned focusing on “case studies” on “cannabinoids” to evaluate the “challenges and safety” of using these chemicals in supplements.

Members of the CBD community are torn over what this latest meeting means for their industry. On the one hand, some hemp brands believe this is a positive sign that the FDA is recognizing the importance of providing regulation for the recreational CBD space. However, many critics believe this meeting will produce no results or give the FDA more impetus to challenge the CBD space.

Although the 2018 US Farm Bill legalized hemp-derived CBD oils, the FDA has yet to introduce a national…